Related Experiment Video
Updated: May 25, 2025

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
Immune-Mediated Bidirectional Causality Between Inflammatory Bowel Disease and Chronic Periodontitis: Evidence from
Zhijun Feng1, Zihan Chen1, Xiaoxu Wang1
1Department of Radiation Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
Genetic analysis reveals a two-way causal link between inflammatory bowel disease (IBD) and periodontitis. Shared molecular pathways and immune regulators like IL1B and CXCR4 underpin this relationship, suggesting new therapeutic targets.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
- Periodontology
Background:
- A bidirectional association exists between inflammatory bowel disease (IBD) and periodontitis.
- The precise causal relationship between these two inflammatory conditions requires further elucidation.
Purpose of the Study:
- To investigate the potential causal links between IBD and periodontitis.
- To explore shared genetic and molecular mechanisms underlying both diseases.
Main Methods:
- Bidirectional Mendelian randomization (MR) analysis was employed.
- Bioinformatics approaches, including differential gene expression and pathway enrichment analysis, were utilized.
- Inverse variance weighting (IVW) and sensitivity analyses assessed causal associations and robustness.
Main Results:
- Significant bidirectional causal associations were identified between IBD and periodontitis.
- Key immune regulators (IL1B, CXCR4) and inflammatory pathways (TNF-α, IL17) were implicated.
- Transcriptomic analysis revealed shared pathological mechanisms and inflammatory mediators.
Conclusions:
- Genetic evidence supports a bidirectional causal relationship between IBD and periodontitis.
- Shared molecular mechanisms and immune factors provide insight into the interplay between these conditions.
- Findings may inform novel therapeutic strategies for IBD and periodontitis.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

